A recent MGMA's 2026 poll found that 48% of practice leaders name denials and appeals as their single largest revenue-cycle leak. ID practices carry extra exposure here: recurring care episodes, facility coordination, authorizations that lapse mid-course, and drug-heavy claims that can hide thousands of dollars in a single rejection.
Recovery isn't just collections. It's prevention, denial correction, underpayment review, A/R follow-up, and workflow fixes working together. This article maps the revenue cycle for ID-specific service lines, shows where leakage hides, and outlines when to investigate or escalate.
Key Takeaways
- Recovery covers prevention, denial correction, underpayment review, and A/R follow-up, not just old balances.
- OPAT, infusion, and buy-and-bill carry risks that generic billing reviews often miss.
- Prioritize fixes using your own denial, aging, and payment data, not industry averages.
- A paid claim isn't automatically a correctly paid claim: underpayments hide inside normal remittances.
- Every recovery action must stay compliant with coding, documentation, and payer rules.
What Is Healthcare Revenue Cycle Recovery?
Healthcare revenue cycle recovery is the process of locating reimbursement that stalled somewhere in the billing cycle, figuring out why, correcting what can legitimately be corrected, and changing the workflow so the same leak doesn't reopen next month.
The goal is simple to state, harder to execute: get paid what you legitimately earned, within payer and filing rules, while keeping records accurate and billing compliant. Recovery stays inside what the service supports and the contract allows. The point is collecting everything you're actually owed.
Recovery vs. Revenue Cycle Management vs. Collections
These terms get used interchangeably, and that creates confusion because they describe different scopes of work:
- Revenue cycle management covers the entire lifecycle of a claim, from the first phone call to the final posted payment.
- Revenue cycle recovery concentrates specifically on the unresolved, delayed, denied, or underpaid revenue inside that lifecycle.
- Patient collections typically means contacting patients about outstanding balances they owe.
- Revenue recovery also covers payer denials, failed authorizations, coding errors, payment variances, and services performed but never billed at all.
A practice can have a technically "functioning" RCM process and still leak tens of thousands of dollars a year through unworked denials or underpayments nobody caught. Recovery is the audit-and-correction layer that catches what normal processing missed.
One boundary matters: recovery is not a license to rebill unsupported services, resubmit claims that lack documentation, or chase patient balances that have not been validated. Every corrected or appealed account needs a documented reason tied to the clinical record and payer contract, not a hunch that "this should have paid more."
This article focuses on operational recovery for the practice: fixing the process that generates and collects revenue, not aggressive debt-collection tactics aimed at patients.
Why Revenue Cycle Recovery Matters and Where It Applies in Infectious Disease Practices
Revenue leakage in ID practices has two lives. It can start before a claim ever gets submitted, through a lapsed authorization or a missed eligibility check. It can also hide after a payment posts, when a check clears but doesn't match the contracted rate. Neither failure triggers an alarm on its own.
ID billing splits into two risk profiles. Cognitive, time-based billing for office visits, consults, and follow-up care often loses money in the documentation.
Drug-heavy billing for OPAT, infusion, and buy-and-bill carries a different exposure: a single denied claim can represent weeks of drug acquisition cost already spent.
Where to Look in Your Own Revenue Cycle
Review these touchpoints using only the services your practice actually bills:
- Office and consult visits: new and established visits, facility consults, and follow-up care where level selection depends on time or medical decision-making
- OPAT, infusion, and buy-and-bill: drug acquisition, administration coding, authorization tracking, and site-of-care matching against the approved location
- Facility and pharmacy coordination: lab result routing, home infusion or skilled nursing handoffs, and clear ownership of the discharge antimicrobial plan
Under buy-and-bill, the practice purchases the drug, holds it as inventory, and bills for both the drug and its administration. A hard denial then becomes a realized loss on goods already consumed.
What a Weak Cycle Costs You
A weak revenue cycle doesn't just slow cash flow. It can cost a practice:
- Earned professional fees on cognitive visits that were under-leveled or under-documented
- Authorized service reimbursement lost to expired or mismatched prior authorizations
- Drug and infusion payment eaten by acquisition cost with no matching reimbursement
- Timely patient-responsibility collections that age past the point of practical recovery
- Management visibility: leadership can't fix what they can't see in their own data
Medicare Part B separately payable drugs are generally paid using average sales price, with administration billed and paid separately from the drug itself, according to CMS's Part B guidance. Missing that distinction on a single claim line is a common, quiet leak.
Signs It's Time to Investigate
Watch for:
- Aging accounts receivable climbing without a clear explanation
- The same denial categories showing up month after month
- Payments that post but don't match your contracted rate
- Staff reworking the same claims repeatedly
- Missing or expired authorization records
- Encounters that were performed but never billed
Before treating any of this as a compliance mandate, verify current CMS, OIG, and payer-contract requirements. Recovery priorities should follow your actual obligations, not a generic checklist.
How Healthcare Revenue Cycle Recovery Works for ID Practices
Recovery works as a closed loop: measure the cycle, validate the account, find the failure point, take the permitted corrective action, track the result, then fix the upstream cause so it doesn't repeat.
Step 1: Establish the Recovery Population
Segment open and historically unresolved accounts by payer, service type, age, balance, denial reason, and filing or appeal deadline. Before pursuing any account, confirm it actually has accurate demographics, coverage details, documentation, coding, and payment history. Recovery work on bad data just wastes more time.
Step 2: Locate the Point of Leakage
Trace the failure back to its origin: referral intake, eligibility, authorization, documentation, charge capture, coding, claim transmission, payer adjudication, payment posting, or follow-up.
For OPAT, infusion, or buy-and-bill claims, compare the clinical workflow against the submitted claim, the authorization record, and the drug or supply documentation. Mismatches here are where drug-heavy claims usually fail.
Step 3: Correct and Pursue the Account
Match the fix to the actual cause:
- Correct administrative data for eligibility or demographic errors
- Submit missing documentation for incomplete claims
- Appeal a valid denial with clinical support
- Investigate an underpayment against the contracted rate
- Contact the patient only once the balance is validated as their responsibility
Every account needs an owner, a next action, a due date, and an escalation rule. Denials and appeals sitting in an unassigned queue are the single fastest way to lose a filing deadline.
Step 4: Convert Findings Into Prevention
Group both recovered and unrecovered accounts by root cause, payer, provider, and workflow stage. One denied drug claim can represent more dollars than a month of office visits combined, so rank root causes by dollar impact, not how often they occur.
Tackle the largest category first, one per month, owned by whoever controls that step, with a deadline attached. Typical fixes include:
- Front-end checklists
- Authorization tracking sheets
- Documentation prompts built into the EHR
- Coding education for cognitive visit levels
- Revised handoffs between clinical and billing staff
Step 5: Monitor the Cycle Over Time
Build a recurring dashboard using measures that fit your service mix:
| Metric | What It Tells You |
|---|---|
| Clean-claim rate | How many claims pass without manual intervention |
| Denial rate by dollars | True exposure on drug-heavy claims, not just claim count |
| Days in A/R | How long cash is tied up (gross vs. net defined) |
| A/R over 90 days (%) | Where authorization and drug-claim problems pile up |
| Payment variance vs. contract | Underpayments that post as "paid" but aren't |
Define each metric clearly and resist chasing one universal "good" benchmark. Clean-claim rate, denial rate, and days in A/R each measure a different stage of the cycle, and the definitions matter more than any target number you've heard quoted elsewhere.
Key Factors, Failure Points, and Recovery Priorities
Four things shape how much revenue an ID practice actually collects:
- Inputs: demographics, authorization records, coding, and drug documentation accuracy
- Operating conditions: payer policy changes, staffing capacity, and filing deadlines
- System dependencies: EHR, clearinghouse, and infusion inventory tools
- Compliance consistency: how thoroughly requirements get followed on every claim
Where Claims Actually Fail
Failures cluster into four stages:
- Front-end failures: incorrect eligibility, missing or expired authorization, incomplete referral data
- Clinical-to-billing disconnects: documentation that doesn't support the billed service, delayed notes, incomplete drug or infusion records
- Claim and coding failures: mismatched diagnosis and procedure codes, missing modifiers, unsupported coding, duplicate claims
- Post-adjudication failures: unworked denials, missed appeal deadlines, unapplied payments, underpayments that look "paid" but don't match the contract
Root-cause categories specific to ID work include:
- Authorization that's absent or lapses mid-course
- Site-of-care mismatches where therapy happens somewhere the payer didn't approve
- Drug-unit and wastage reporting errors
- Under-documentation of antimicrobial medical necessity
Three Misconceptions Worth Correcting
- Recovery isn't aggressive collections. It's validation and correction first, outreach second.
- A paid claim isn't automatically a correctly paid claim. Underpayments post as normal-looking remittances with no rejection and no alert.
- More billing activity doesn't mean more collected revenue. Technology organizes the work; it doesn't replace clinical documentation or payer knowledge.
What Root-Cause Review Can Look Like
Graves Gilbert Clinic, a physician group in Bowling Green, Kentucky, brought in a third-party review of its revenue cycle. According to MGMA's 2020 report on the group's CFO, daily denials fell to an average of seven against a volume tied to roughly 700 daily authorizations.
The lesson isn't the specific number. Denials are usually evidence of a process failure, not a one-off mistake. An outside look at root causes can surface patterns an internal team is too close to see.
When Recovery May Not Be the Right First Step
Recovery isn't always the right starting point. Jump straight to outreach or aggressive collection before you've validated a balance, confirmed payer responsibility, or exhausted a pending appeal, and you risk writing off money you could have recovered. You may also bill a patient for something the payer still owes.
Fix the workflow first when you're dealing with:
- A new EHR or practice-management system implementation
- Recurring registration errors at intake
- Missing or incomplete provider enrollment
- Widespread authorization failures across payers
- Documentation workflows that consistently fail audits
Some balances simply aren't worth chasing. Pursuit loses value, or becomes pointless, when you face:
- Expired filing or appeal windows
- Services lacking supporting documentation
- Contractual write-off limits
- Balances smaller than the cost of compliant follow-up
When to Bring in Outside Help
External review makes sense when:
- Aged accounts keep climbing despite internal effort
- Payer variance on drug claims is too complex to untangle in-house
- Staffing can't keep pace with denial and appeal volume
- OPAT or infusion reconciliation issues keep recurring
- Leadership can't get reliable revenue-cycle reporting out of current systems
If you want a clearer read on your own numbers before committing, GrowInfectiousDisease publishes free, ungated explainers and browser-based calculators. Those tools model infusion, OPAT, and office revenue against your staffing and drug costs, so you work from actual figures instead of borrowed industry assumptions.
Conclusion
Healthcare revenue cycle recovery for infectious disease practices is a feedback loop, not a one-time cleanup project. It covers prevention, account validation, correction, follow-up, payment accuracy, and fixing the root cause so the same leak doesn't reopen next quarter.
Understanding how revenue actually moves through office visits, consults, OPAT, infusion, and buy-and-bill helps physicians and administrators separate genuine clinical complexity from preventable operational leakage. Clinical complexity and operational leakage need different fixes.
Evidence beats assumption here. Don't adopt a benchmark, a piece of software, or a collection tactic just because it worked somewhere else.
Start small:
- Pick a defined review period
- Map claims and payments by service line and payer
- Find your largest recurring failure point
- Assign someone to own the fix, with a date attached
Frequently Asked Questions
What is revenue recovery?
Revenue recovery is the process of identifying, correcting, and collecting delayed, denied, underpaid, or otherwise unresolved healthcare reimbursement while fixing the workflow that caused it. It's broader than collections; it includes prevention and root-cause correction too.
What are the steps of the revenue cycle?
The cycle covers registration, eligibility, authorization, documentation, coding, claim submission, adjudication, payment posting, denial or appeal work, and final resolution. Patient billing applies only when a balance is validated as patient responsibility.
How long do I have to appeal a denied Medicare claim?
For Original Medicare, a redetermination request must be filed within 120 days of receiving the initial determination, with receipt presumed five days after the notice date. Commercial and Medicare Advantage deadlines vary by contract.
What's different about recovery for OPAT and infusion claims?
Drug-heavy claims carry acquisition cost risk that office visits don't. A single denied buy-and-bill claim can represent weeks of inventory already purchased and administered, so these denials need dollar-based prioritization, not just count-based tracking.
How often should a practice review payment accuracy?
A quarterly review of high-value drug and infusion claims against contracted rates is a reasonable starting cadence, since underpayments typically post without any rejection or alert to flag them.
